Multiple Myeloma: Diagnosis and Risk Assessment | Dana-Farber Cancer Institute 

Nikhil C. Munshi, MD, Director of Basic and Correlative Science at the Jerome Lipper Multiple Myeloma Cancer and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute and Professor of Medicine at Harvard Medical School, discusses diagnosis and risk assessment in multiple myeloma. This presentation was originally given at the Multiple Myeloma Patient Education Symposium on Dec. 10, 2016 in Boston, MA.

Наука